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Abstract. Specificity H-2.7 is expressed predominantly on erythrocytes and controlled by a gene 
that maps within the H-2 gene complex at a locus, designated as H-2G, which apparently lies between 
regions S and D. Three phenotypes have been observed with respect to this antigen: a) positive 
by direct test and absorption (haplotypes 11-2 f, H-2 j, H-2 p, H-2~); b) positive only by absorption 
(H-2k); and c) negative (H-2 b, H-2 d, 11-2~ New crossover positions have been established for several 
H-2 recombinants based on classifications for the H-2G locus. 
Introduction 
Specificity H-2.7 was first defined by Hoecker et al. (1959) with an A anti- 
A.CA antiserum tested against A.SW (H-2 ~) cells in the hemagglutination test. 
It was later shown that A anti-A.SW serum tested against A.CA (H-2 ~) detects 
H-2.7 as well (Shreffler and Snell 1969). Further analysis based on hemagglutina- 
tion tests showed that H-2.7 is also determined by haplotypes H-2 p and H-2 j. 
Several other antisera were shown to detect H-2.7 by the hemagglutination test. 
The same antisera used against the same target cells in the cytotoxic test were 
assumed also to detect H-2.7. Several intra-H-2 recombinants have been classified 
for H-2.7. Recombinant B10.M(l lR)  [H-2apl], which is K f D  a, was found to 
be +H-2.7,  and B10.M(17R) [H-2a~l], which is K~D I, was -H-2 .7 .  Both strains 
were typed by hemagglutination (Stimpfling and Richardson 1965). This sug- 
gested localization to the Kregion. Recombinants A.TL (H-2 tl) and A.TH (H-2tz), 
which are KSD a, were classified as - H - 2 . 7  on the basis of cytotoxic tests (David 
and Shreffler 1972). This suggested localization to the D region. Stimpfling 
et al. (1971) suggested that H-2.7 may be located to either side of S due to 
duplicated genes. In an attempt to resolve this question we recently reanalyzed 
several of the H-2 haplotypes for H-2.7 specificity by both the hemagglutina- 
tion and cytotoxic tests. In this paper we present evidence which indicates that 
H-2.7 is expressed predominantly on erythrocytes and is controlled by an indepen- 
dent locus, designated H-2G, which maps between regions S and D of the H-2 
gene complex. 
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Materials and Methods 
Most of the mouse strains used in this study were obtained either from the colony maintained 
in the Department of Human Genetics, University of Michigan, or the colony in the McLaughlin 
Research Institute, Great Falls, Montana. Strains BSVS and LG/Ckc were kindly provided by Dr. 
M. Doff and Dr, G. Snell, respectively. 
All testing was done by the PVP hemagglutination test (Stimpfling 196l) as well as by the 
SlCr-release method, with lymph node target cells (Snell et al. 1971). In vivo absorptions were 
performed by injecting 0.1 rnl of the antiserum, intraperitoneally, bleeding the animal 3 hours later, 
and checking for residual antibody activity (Shreffier et  al. 1966). In vitro absorptions were performed 
by incubating appropriate dilutions of antisera with varying volumes of packed erythroc~tes or 
varying cell numbers of lymphocytes, centrifuging the suspension, and checking the supernatant 
for residual antibody activity against selected target cells in the hemagglutination test. 
Results 
Hemagglu t ina t ion  Tests  
Three antisera were tested against all the available haplotypes : a) (B6 x A)F~ 
anti-B10.P [anti-H-2.7,16]; b) (C3H.SWxB10.A)F~ anti-C3H.NB [anti-H- 
2.7,16]; c) A anti-A.SW [anti-H-2.7,19]. Table 1 shows the results of direct tests 
with selected haplotypes. As previously demonstrated, haplotypes H - 2  •, H - 2  p 
and H-2  s were all positive for H-2.7. Among the five H-2  t haplotypes with identical 
K and D regions, only H - 2  ~2 gave a positive H-2.7 hemagglutination reaction. 
(All five H-2t 's  were positive with serum A anti-A.SW, which contained anti-19 
antibodies). H - 2  '3 and 11-2 '~ differ from H - 2  t2 only in the I - C  and D regions, 
while H-2  ts differs from H-2  t2 only in the S and D regions. Since H-2 ~ strains 
are positive for H-2.7 by hemagglutination and H-2  d and H - 2  k strains are negative, 
this reaction is apparently due to a gene between the I and D regions. The 
region controlling H-2.7 was further narrowed by the positive reaction of strain 
A.TFR1 (H-2a"l), which is S k and D ~. Since other S k strains fail to give direct 
hemagglutination and the results cited above place the determinant of this reactiv- 
ity to the left of D on the basis of direct hemagglutination, H-2.7 appears 
to be controlled by an independent locus between S and D. This region is tenta- 
tively designated H-2G,  since Snell et al. (1973) had previously hypothesized a 
locus (designated H-2G)  in this interval to account for some observations with 
another antiserum. Several other recombinants [A.TFR3, A.TFR5, LG/Ckc, 
A.QSRI] provide additional evidence for this map location. Previous results 
with BI0.M(11R) and BI0.M(17R) also are in agreement with this map position. 
B 10. M(11 R) is apparently K~GYD a ( + H-2.7) while B 10. M(17R) must be KeGdD I 
(-H-2.7), since H-21 is positive and H-2  e is negative for H-2.7. 
C y t o t o x i c  Tes ts  
Cytotoxic tests with anti-H-2.7 gave some anomalous results, suggesting in- 
volvement of other specificities. Antiserum (B6xA)F 1 anti-Bl0.P was tested 
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Table 2. Direct Cytotoxic Reactions of Antiserum (B6 x A)F1 Anti-B10.P Against Recombinant 
Haplotypes a 
Strain Haplotype H-2 Region Cytotoxic 
Titer 
K I S D 
A.TFR1 an1 s k k~ f 0 
A.TFR3 ap3 f J~ s d 320 
A.TFR5 ap5 f f~ k d 320 
A.QSR1 sql s ~ q q 0 
B10.AKM m k k k~ q 0 
AQR yl  q [~ k d 0 
B10.T(6R) y2 q q q~ d 320 
LG/Ckc arl d ~f f f 320 
a Arrows indicate map position of reactivity. 
the independent haplotypes, C 3 H . Q ( H - 2  q) was positive, while B10.S(H-2 s) was 
negative. With these target cells, a 40-50% release was obtained, compared with 
a background of 20%. In the hemagglutination test H-2 ~ was positive, while 
H-2 q was negative. Examination of the recombinant hyplotypes clarified these 
results. 
Three strains mapped the cytotoxic reactivity to the left of S (Table 2). 
Strains A.TFR3 and A.TFR5 were positive, while A.QSR1 was negative. Since 
parental haplotypes H-2 s, H-2  k and H-2  a were negative and H-2:  and H-2 q were 
positive, the cytotoxic reactivity must be controlled by a gene(s) to the left of 
S. Strain AQR was negative and LG/Ckc was positive, indicating that the K 
region does not control this reaction. This confines the reactivity to a position 
between K and S in the I region. The reactivity is due to antibodies against 
an Ia specificity determined by F,  which crossreact with products of F and 
I q. It is designated Ia. 13. Further data on this specificity will be reported elsewhere. 
These results show that specificity H-2.7 was not involved in the cytotoxic 
reaction. Some of the difficulties in previous classifications of certain strains 
for H-2.7 arose from interpreting the cytotoxic reaction as due to anti-7. H-2.7 
was originally defined as a hemagglutinating specificity and apparently cannot 
be detected on lymphocytes by direct cytotoxicity. 
In Vivo Absorptions 
To check the positive hemagglutination results, in vivo 'absorptions were 
done with antiserum (B6 x A)F 1 anti-B 10.P in mice of all independent H-2 haplo- 
types. The absorbed sera were tested by hemagglutination against cells from 
B10.P (H-2.7,16;Ia.13), B10.K (negative), B10.S(H-2.7), and B10.M (H-2.7; 
Ia.13) (Table 3). As expected, B10.P cleared reactivity for all test cells, while 
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Table 3. In Vivo Absorptions of Antiserum (B6 x A)F 1 Anti-B10.P in Strains Carrying Independent 
Haplotypes 
Absorbed In Haplotype Tested Against" 
BI0.P B10.K B10.S B10.M 
Bl0 b > 80 0 40 20 
B10.D2 d > 80 0 80 40 
A.CA f > 80 0 0 0 
B10.K k >80 0 0 0 
B10.P p 0 0 0 0 
C3H.Q q >80 0 >80 >80 
B10.S s >80 0 0 0 
a Titer by bemagglutination. 
Table 4. In Vivo Absorptions of Antiserum (B6 x A)F 1 Anti-B 10.P in Strains Carrying Recombinant 
Haplotypes 
Absorbed H-2 Regions Tested Against a 
In 
K I S D B10.P B10.K B10.S B10.M 
A.TL s k k d > 80 0 0 0 
A.TH s s s d >80 0 0 0 
BI0.HTT s s k d >80 0 0 0 
A.AL k k k d > 80 0 0 0 
C3H.OH d d d k >80 0 >80 >80 
C3H.OL d d k k >80 0 0 0 
B10.AM k k k b >80 0 0 0 
B10.AKM k k k q >80 0 0 0 
A.TFR5 f f k d > 80 0 0 0 
a Titer by hemagglutination. 
B10 and B10.D2 failed to clear. Strains A.CA and B10.S cleared anti-H-2.7. 
However, unexpectedly B10.K cleared the anti-H-2.7 reactivity against B10.S 
and B10.M test cells. This was repeated several times, and haplotype H-2 k was 
found to be consistently positive for H-2.7 by absorption, but negative by direct 
test (HANAP-hemagglutination negative, absorption positive). 
In vivo absorptions were also done in mice of a number of different recom- 
binant haplotypes to check the results of direct tests (Table 4). As expected, 
the C3H.OL strain, which is SkD k, absorbed the antiserum. Strain A.AL (SkD a) 
also absorbed the antiserum, suggesting that it carries an H-2G k allele and placing 
the crossover point to the right of H-2G. Three strains, which derived their 
D end from A.AL [A.TL, B10.HTT, and A.TFR5], also absorbed for H-2.7. 
Strains B10.AM (SkD b) and B10.AKM (SkD ~) also absorbed, again suggesting 
crossover positions to the right of H-2G. Strain C3H.OH (SaD k) failed to absorb, 
indicating an H-2G d allele and a crossover to the right of H-2G. As expected, 
all recombinants positive by direct test [A.TH, B10.S(TR), A.TFR1, A.TFR3, 
and LG/Ckc] absorbed for H-2.7. 
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In Vitro Absorptions 
Erythrocytes: Quanti tat ive absorpt ions  were performed with erythrocytes f rom 
strains B10.S, B10.D2, and B10.K and tested by hemagglut inat ion against target 
cells f rom B10.S, B10.M, and B10.P (Table 5). B10.D2 red b lood cells failed 
to absorb  for  any o f  the target cells. A volume of  0.05 ml o f  packed B10.S 
erythrocytes was required to absorb  for B10.S and B10.M (H-2.7) target cells 
but  complete absorpt ion was not  obtained for B10.P (H-2.7,16) targets. In con- 
trast, 0.5 ml of  packed B10.K erythrocytes was required to absorb for B10.S 
and B10.M target cells, a volume l0 times greater than in the previous case. 
This is consistent with the failure of  direct hemagglut inat ion with B 10.K erythro-  
cytes, suggesting a low dinsity o f  antigenic sites on these cells. 
Lymphocytes: Quanti tat ive absorpt ions  were also done with lymphocytes  f rom 
lymph nodes, spleen and thymus  (Table 6). N o  absorpt ion was seen with B10.D2 
lymphocytes,  when the absorbed serum was tested by hemagglut inat ion against 
B10.S, B I0 .M and B10.P target cells. The concentra t ion o f  lymph node  cells 
f rom strain B10.S required to absorb  reactivity against BI0.S and B10.M target 
cells was 107, but  up to 200 x 10 6 B10.S cells failed to absorb  for B10.P. In 
comparison,  only 106 B10.P cells were required to absorb anti-H-2.16 reactivity 
f rom the same volume and concentra t ion of  antiserum when tested by hemagglu-  
t ination against B10,P erythrocytes  (Data  no t  included in Table 6). As many  
as 108 B10.S thymus  and spleen cells were required to absorb  the anti-H-2.7 
reaction with B10.S and B10.M erythrocytes.  L y m p h  node  cells (50 million) 
Table 5. In Vitro Absorptions of (B6 x A)F 1 Anti-B10.P (Anti-7.16) with Erythrocytes 
Target Cells Absorbed In ~ 
BI0.S B10.D2 B10.K 
B10.S 0.05 ml NA 0.5 ml 
B10.M 0.05 ml NA 0.5 ml 
B 10.P NA NA NA 
" Volume of cells (packed) required to completely absorb 0.1 ml of antiserum diluted 1/100. NA 
indicates no absorption with up to 1 ml packed erythrocytes. 
Table 6. In Vitro Absorptions of (B6 x A) F1 Anti-B10.P (Anti-7,16) with Lymphocytes 
Target Absorbed In a 
Cells 
B10.S BI0.K B10,D2 
LN TH SP LN TH SP LN TH SP 
B10.S 10 100 100 50 NA NA NA NA NA 
BI0.M 10 100 100 50 NA NA NA NA NA 
BI0.P NA NA NA NA NA NA NA NA NA 
Number of cells (million) required to completely absorb 0.1 ml of antiserum 1/100. NA indicates 
no absorption with up to 200 million lymphocytes. 
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from B10.K absorbed the anti-H-2.7, but no absorption could be detected with 
up to 200 million thymus and spleen cells. These results suggest that specificity 
H-2.7 is expressed on H-2 s lymph node lymphocytes at a density 10 to 20 times 
less than that of classical H-2 antigens, and the density on H-2 k lymph node 
cells is even lower. The expression on thymic and spleen cells is still weaker. 
Discussion 
Most of the initially defined H-2 specificities were identified by the hemagglu- 
tination method. When the antisera which defined these specificities were tested 
by the cytotoxic method, they were assumed to be detecting the same specificities. 
Specificity H-2.7 is an example of such a case. Several anti-H-2.7 sera gave 
good reactions in both the hemagglutination and cytotoxicity assays. However, 
discrepancies between the results of these assays when these sera were tested 
against intra-H-2 recombinants suggested that we were dealing with two different 
specificities, mapping in separate regions. This raises the possibility that still 
other H-2 specificities apparently localized to the D or K regions might be sepa- 
rable from the H-2D and H - 2 K  genes. Such reactivity in the D region could 
be due to other alleles at the H-2G locus. 
We have only preliminary data on the histocompatibility properties of the 
H-2G antigen. Skin grafts between strains carrying haplotypes differing at this 
locus do not show a classical H-2 (K or D) rejection pattern [12-14 days]. 
Rejection is obtained 60-90 days after grafting, if the recipient is presensit- 
ized (Stimpfling, unpublished). This pattern is similar to that of the weaker 
histocompatibility loci. However, since the haplotype combinations tested so 
far also differ in the S and I -C regions, whether genes determining the erythrocyte 
antigens are identical to those determining these minor histocompatibility differ- 
ences cannot be determined as yet. 
The inability to detect H-2.7 specificity by direct cytotoxic tests on lymphocytes 
could be interpreted in two ways: a) either the density of the antigenic sites 
on the lymphocytes is too sparse for proper complement binding or b) the anti- 
bodies are noncomplement fixing. Since H=2 k erythrocytes do not give a direct 
reaction in the hemagglutination or cytotoxic test, the most probable explanation 
would be the low density of antigenic sites on the cell surface. The almost negligible 
expression on thymic and splenic lymphocytes is also unlike that of other H-2 
antigens. Further studies on the tissue distribution of the H-2.7 antigen are 
in progress. 
It would be interesting to know whether antigens coded by the H-2G loci 
are on molecules independent of H-2D or on the same molecule. If they are 
on different molecules, do they differ in molecular weight and other chemical 
properties? Such studies may be difficult due to the low density of H-2.7 on 
lymphocytes. 
The genetic compositions of several recombinant haplotypes with regard to 
the H-2 gene complex are shown in Table 7. On the basis of current information 
on the H-2G locus, new crossover points have been assigned to several of the 
recombinants. The recombinant haplotypes of strains A.AL, C3H.OH, B10.AM, 
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Table 7. Composi t ions of the H-2 Gene Complex in Some Recombinant  Haplotypes 
Strain Haplo- H-2 Region a H-2.7 
type Reactivity 
K I -A  I -B  I - C  S G D 
Direct ABS 
Test 
B10.A a k k k I d d d d - - 
A.AL a l  k k k k k k I d - + 
C3H.OL o l  d d d d I k k k - + 
C3H.OH 02 d d d d d d I k -- -- 
B10.AM h3 k k k k k k I b - + 
BI0 .AKM m k k k k k k I q - + 
A.QSR1 s q l  s s s s [ q q q - - 
A,TH t2 s s s s s s I d + + 
A.TL t l  s I k k k k k d - + 
B10.HTT t3 s s s I k k k d - + 
B10.S(9R) t4 s s s I d d d d - - 
BSVS t5 s s s s I d d d - - 
A.TFRI  a n l  s k k k k [ f f + + 
A.TFR3 ap3 f f f f I s s d + + 
A.TFR5 ap5 f f f f [ k k d - + 
LG/Ckc  ar l  d [ f f f f f f + + 
a Vertical lines indicate crossing over points. 
B10.AKM, and A.TH seem to have derived from crossover between the G and 
D regions. So far only haplotype H-2 ""1 (A.TFR1) seems to have a crossover 
point between S and G, but four haplotypes, H-2 ~ (C3H.OL), H-2 t5 (BSVS), 
H-2 "p3 (A.TFR3), and H-2 ap5 (A.TFR5), carrying crossovers between the I-C 
and S regions, separate the H-2G locus from the I region. 
Since the H-2 b, H-2 d, and H-2 q haplotypes completely lack the H-2.7 antigen, 
an interesting question is whether allelic products at the H-2G locus are determined 
by these haplotypes. Likewise, does the H-2 ~ haplotype produce an H-2G product 
which is qualitatively different from those of H-2 I, H-2 j, 11-2 p, and H-2S? Experi- 
ments are underway to attempt to detect other antigens controlled by the H-2G 
locus. 
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